You are here

RAC Vaccines and Vaccination Group

Primary tabs

RAC Workgroup Efforts Focused on Vaccines and Vaccination

The Resilient American Communities (RAC) Vaccines and Vaccination Group is examining and acting on the issues surrounding vaccines development, distribution, vaccination logistics and execution, as well as vaccination strategy, safety, efficacy, trust, and hesitancy.  Special attention is currently focused on COVID-19 vaccines and vaccination. 

Members

Hank Rappaport Jan Booher John Girard Kathleen H mdmcdonald mike kraft

Email address for group

rac-vaccination@m.resiliencesystem.org

Reduced risk of long COVID after vaccination shown in analysis of 25 studies

A new meta-analysis of studies involving more than 14 million people published in the Journal of Infection shows that COVID-19 vaccination is associated with a lower risk of developing long COVID, with two doses reducing the odds by 24% and one dose reducing the odds by 15%.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Mpox: Burundi reluctant to accept vaccines despite outbreak; new case in England

...Donated vaccine doses are available to Burundi for free but “vaccine hesitancy” might be playing a part in the government’s reluctance to vaccinate people, according to Dr Ngashi Ngongo, mpox lead for the Africa Centres for Disease Control and Prevention. ...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Analysis: Concern About How Trump’s Health Nominee Covid Contrarians Will Handle the Next Pandemic

President-elect Donald J. Trump had already succeeded in rattling the nation’s public health and biomedical establishment by the time he announced on Tuesday that he had picked Dr. Jay Bhattacharya to run the National Institutes of Health. But amid growing fears of a deadly bird flu pandemic, perhaps no one was more rattled than experts in infectious disease.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

No unexpected COVID vaccine safety concerns in young children--study

A new research letter published yesterday in JAMA Network Open shows no new safety concerns or reactogenicity signals among babies and toddlers who received their first COVID-19 vaccines by the age of 2.

...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

howdy folks
Page loaded in 0.749 seconds.